在患有严重状细胞贫血的患者中输血聚合人体血红蛋白
Joshua P Raff1, Cassandra E Dobson, Han-Mou Tsai
1Division of Haematology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA.
Lancet (London, England)
|September 21, 2002
概括
聚合人体血红蛋白溶液缓解了状细胞贫血患者的疼痛,当不存在兼容血液时. 这种治疗,与红色素,改善了血红蛋白水平,并导致恢复.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
- 状细胞疾病 状细胞疾病
背景情况:
- 状细胞贫血 (SCA) 患者经常产生红细胞附抗体,使输血复杂化.
- 对于SCA患者来说,寻找兼容的血液可能是一项挑战,尤其是在危机期间.
相关概念视频
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...


